Synlett 2013; 24(2): 185-188
DOI: 10.1055/s-0032-1317943
letter
© Georg Thieme Verlag Stuttgart · New York

Application of a Dual Fries–Claisen Protocol to Access Pyranonaphthoquinone Natural Products

Liam J. Duffy
a   Research Institute for the Environment, Physical Sciences and Mathematics, Keele University, Keele ST5 5BG, UK
,
Jason Garcia-Torres
b   Chemistry Department, Loughborough University, Loughborough, Leics LE11 3TU, UK
,
Raymond C. F. Jones
b   Chemistry Department, Loughborough University, Loughborough, Leics LE11 3TU, UK
,
Mark R. J. Elsegood
b   Chemistry Department, Loughborough University, Loughborough, Leics LE11 3TU, UK
,
Steven M. Allin*
c   School of Science & Technology, Nottingham Trent University, Clifton, Nottingham NG11 8NS, UK   Email: steve.allin@ntu.ac.uk
› Author Affiliations
Further Information

Publication History

Received: 23 November 2012

Accepted: 02 December 2012

Publication Date:
18 December 2012 (online)


Abstract

In this paper we describe the application of a recently developed dual Fries–Claisen protocol as a novel synthetic approach to the pyranonaphthoquinone natural products eleutherin and isoeleutherin.

 
  • References and Notes

    • 1a Uno H. J. Org. Chem. 1986; 51: 350
    • 1b Kraus GA, Molina MT, Walling JA. J. Org. Chem. 1987; 52: 1273
    • 1c Brimble MA, Lynds SM. J. Chem. Soc., Perkin Trans. 1 1994; 493
    • 1d Salaski EJ, Krishnamurthy G, Ding W.-D, Yu K, Insaf SS, Eid C, Shim J, Levin JI, Tabei K, Toral-Barza L, Zhang W.-G, McDonald LA, Honores E, Hanna C, Yamashita A, Johnson B, Li Z, Laakso L, Powell D, Mansour TS. J. Med. Chem. 2009; 52: 2181
  • 2 Sperry J, Lorenzo-Castrillejo I, Brimble MA, Machin F. Bioorg. Med. Chem. 2009; 17: 7131
  • 3 Hong J.-H, Yu ES, Han A.-R, Nam J.-W, Seo E.-K, Hwang ES. Biochem. Biophys. Res. Commun. 2008; 371: 278
  • 4 Song S.-H, Min H.-Y, Han A.-R, Nam J.-W, Seo E.-K, Park SW, Lee SH, Lee SK. Int. Immunopharmacol. 2009; 9: 298
  • 5 Gibson J, Andrey O, Brimble MA. Synthesis 2007; 2611
  • 6 Sawant RT, Jadhav SG, Waghmode SB. Eur. J. Org. Chem. 2010; 4442
  • 7 Fernandes RA, Chavan VP, Ingle AB. Tetrahedron Lett. 2008; 49: 6341
  • 8 Tewierik LM, Dimitriadis C, Donner CD, Gill M, Willems B. Org. Biomol. Chem. 2006; 4: 3311
  • 9 Kobatashi K, Uchida M, Uneda T, Tanmatsu M, Morikawa O, Konishi H. Tetrahedron Lett. 1998; 39: 7725
  • 10 Duffy LJ, Garcia-Torres J, Jones RC. F, Allin SM. Synlett 2012; 23: 1821
    • 11a X-ray crystal data for 7: C23H21IO5, M = 504.30, monoclinic, space group P21/c, a = 14.3715(5), b = 15.6087(5), c = 9.0761(3) Å, β = 94.3888(5), V = 2029.98(12) Å3, T = 150 K, Z = 4, crystal dimensions 0.56 × 0.22 × 0.12 mm3, Mo–Kα monchromated radiation (λ = 0.71073 Å), μ = 1.610 mm–1, 23393 data measured using a Bruker APEX 2 CCD diffractometer. 6173 data were unique, R int = 0.022; all unique data used in refinement against F 2 values to give final wR = 0.0622 (on F 2 for all data), R = 0.0236 {for 5369 data with F 2 >4σ(F 2)}. Programs used were Bruker APEX 2 (see ref. 11b), SAINT (see ref. 11b), SHELXTL (see refs. 11c and 11d) and local programs. Crystallographic data (excluding structure factors) for the structure in this paper has been deposited with the Cambridge Crystallographic Data Centre as supplementary publication number CCDC 854341. Copies of the data can be obtained, free of charge, on application to CCDC, 12 Union Road, Cambridge, CB2 1EZ, UK [Fax: +44(1223)336033 or e-mail: deposit@ccdc.ac.uk].
    • 11b APEX 2 and SAINT Software for CCD Diffractometers. Bruker AXS Inc; Madison WI: 2008
    • 11c Sheldrick GM. SHELXTL User Manual, Version 5. Bruker AXS Inc; Madison WI: 1994
    • 11d Sheldrick GM. Acta Crystallogr., Sect. A 2008; 64: 112
  • 12 Synthesis of Eleutherin Precursor, 11a: Step (1): Methyllithium (2.01 mL, 3.23 mmol; 1.6 M solution in decane) was added dropwise to 5,9,10-trimethoxy-3-methyl-3,4-dihydro-1H-benzo[g]isochromen-1-one (9; 813 mg, 2.69 mmol) in anhyd THF–Et2O (1:1; 50mL) at 0 °C. The reaction mixture was stirred vigorously and allowed to reach r.t. overnight. The reaction was stopped by careful addition of sat. aq NH4Cl (50 mL) and the aqueous layer was extracted three times with EtOAc (3 × 30 mL). The combined organic phases were dried over anhyd MgSO4 and concentrated under reduced pressure. The crude white foam recovered (10, 856 mg) was taken forward to the lactol reduction step without purification. Step (2): Lactol 10 (856 mg, 2.69 mmol) was dissolved in anhyd CH2Cl2 (20 mL) and cooled to −78 °C before successive dropwise addition of BF3·OEt2 (1.02 mL, 8.07 mmol) and TES (1.29 mL). The red solution was stirred vigorously for 1 h at −78 °C before being allowed to warm to r.t. over 2 h. The reaction was carefully quenched with the addition of H2O (50 mL) and then partitioned between brine (50 mL) and CH2Cl2 (50 mL). The organic layer was separated and the aqueous phase was extracted twice more with CH2Cl2 (2 × 30 mL). The combined organics were dried over anhyd MgSO4 and evaporated to dryness under reduced pressure. The crude 1H NMR spectrum of this material showed a 5:1 cis/trans mixture of (±)-11a and (±)-11b, respectively. The mixture of naphthopyrans was chromatographed on silica using light petroleum (bp 40–60 °C)–EtOAc (6:1) as eluent to yield 11a as a white solid (550 mg, 68% over 2 steps). It was not possible to separate the trans-naphthopyran 11b from the cis-naphthopyran, (±)-11a, at this juncture, only 136 mg (17% over 2 steps) of a mixture (1:1 by 1H NMR spectroscopy) was isolated (total combined yield 85%). Data for 11a: mp 104–106 °C (Lit.1a mp 106–107 °C). IR (ATR): 1570, 1071, 1058 cm–1. 1H NMR (300 MHz, CDCl3): δ = 1.42 (d, J = 6.0 Hz, 3 H), 1.69 (d, J = 6.0 Hz, 3 H), 2.59 (dd, J = 11.1, 16.2 Hz, 1 H), 3.06 (dd, J = 1.8, 16.2 Hz, 1 H), 3.65–3.71 (m, 1 H), 3.77 (s, 3 H), 3.99 (s, 3 H), 4.01 (s, 3 H), 5.25 (q, J = 6.0 Hz, 1 H), 6.83 (d, J = 7.5 Hz, 1 H), 7.37 (t, J = 8.1 Hz, 1 H), 7.68 (dd, J = 0.6, 8.4 Hz, 1 H). 13C NMR (100 MHz, CDCl3): δ = 21.9, 23.2, 31.9, 56.1, 61.2, 61.6, 69.4, 71.3, 105.4, 114.5, 119.3, 125.9, 126.1, 129.8, 130.3, 148.5, 149.1, 156.1. MS (EI–CI): m/z [M + H+] calcd for C18H22O4: 303.1591; found: 303.1596.
  • 13 Synthesis of Eleutherin (3a): A solution of cerium(IV) ammonium nitrate (1.99 g, 3.64 mmol) in H2O (2 mL) was added to a solution of the cis-naphthopyran (±)-11a (550 mg, 1.82 mmol) in MeCN (4 mL) at r.t. After stirring for 2 h, the reaction was partitioned between CH2Cl2 (50 mL) and H2O (50 mL). The organic phase was separated and the aqueous phase was re-extracted twice with CH2Cl2 (2 × 30 mL). The combined organic fractions were washed with brine, dried over anhyd MgSO4 and concentrated under reduced pressure. The crude quinone was chromatographed on silica gel using light petroleum (bp 40–60 °C)–EtOAc (2:1) as eluent to give (±)-eleutherin (3a) as a yellow solid (462 mg, 93%). Data for 3a: mp 156–157 °C (Lit.1a mp 155–156 °C). IR (ATR): 1651, 1584, 1276, 1059 cm–1. 1H NMR (300 MHz, CDCl3): δ = 1.37 (d, J = 6.0 Hz, 3 H), 1.54 (d, J = 6.0 Hz, 3 H), 2.20 (ddd, J = 3.6, 10.2, 18.3 Hz, 1 H), 2.75 (dt, J = 2.7, 18.3 Hz, 1 H), 3.56–3.62 (m, 1 H), 4.00 (s, 3 H), 4.83–4.89 (m, 1 H), 7.28 (d, J = 8.1 Hz, 1 H), 7.64 (t, J = 7.8 Hz, 1 H), 7.73 (dd, J = 0.9, 7.5 Hz, 1 H). 13C NMR (100 MHz, CDCl3): δ = 20.8, 21.3, 29.9, 56.5, 68.7, 70.3, 117.7, 119.0, 120.2, 133.9, 134.6, 139.9, 148.7, 159.4, 183.8, 184.1. MS (EI–CI): m/z [M + H+] calcd for C16H16O4: 273.1121; found: 273.1124.
  • 14 Isolation of an Analytical Sample of Isoeleutherin (3b): A solution of cerium(IV) ammonium nitrate (493 mg, 0.90 mmol) in H2O (1 mL) was added to a solution of 1:1 (±)-11a/b (136 mg, 0.90 mmol) in MeCN (2 mL) at r.t. After 2 h stirring the reaction was partitioned between CH2Cl2 (50 mL) and H2O (50 mL). The organic phase was separated and the aqueous phase was extracted twice more with CH2Cl2 (2 × 30 mL). The combined organic fractions were washed with brine, dried over anhyd MgSO4 and concentrated under reduced pressure. The crude quinone was chromatographed on silica gel using light petroleum (bp 40–60 °C)–EtOAc (4:1) as eluent to give a 1:1 mixture of (±)-eleutherin (3a) and (±)-isoeleutherin (3b) as a yellow solid (109 mg, 89%). It was only possible to isolate an analytical sample (7 mg) of (±)-isoeleutherin (3b) as a yellow solid for characterisation purposes; mp 151–152 °C (Lit.1a mp 154–155 °C). IR (ATR): 1651, 1584, 1276, 1058 cm–1. 1H NMR (300 MHz, CDCl3): δ = 1.35 (d, J = 6.0 Hz, 3 H), 1.54 (d, J = 6.9 Hz, 3 H), 2.24 (ddd, J = 2.1, 10.2, 19.2 Hz, 1 H), 2.70 (dd, J = 3.3, 18.9 Hz, 1 H), 3.96–4.01 (m, 1 H), 4.01 (s, 3 H), 5.02 (q, J = 6.6 Hz, 1 H), 7.29 (d, J = 8.7 Hz, 1 H), 7.66 (t, J = 7.8 Hz, 1 H), 7.76 (dd, J = 0.9, 7.5 Hz, 1 H). 13C NMR (100 MHz, CDCl3): δ = 19.8, 21.5, 29.5, 56.5, 62.4, 67.4, 117.8, 119.1, 119.3, 134.0, 134.8, 139.4, 148.0, 159.7, 182.8, 184.3. MS (EI–CI): m/z [M + H+] calcd for C16H16O4: 273.1121; found: 273.1127.